CY1124087T1 - Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων - Google Patents

Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων

Info

Publication number
CY1124087T1
CY1124087T1 CY20211100437T CY211100437T CY1124087T1 CY 1124087 T1 CY1124087 T1 CY 1124087T1 CY 20211100437 T CY20211100437 T CY 20211100437T CY 211100437 T CY211100437 T CY 211100437T CY 1124087 T1 CY1124087 T1 CY 1124087T1
Authority
CY
Cyprus
Prior art keywords
protein kinase
kinase inhibitors
pyridoquinazoline
derivatives useful
ameliorated
Prior art date
Application number
CY20211100437T
Other languages
Greek (el)
English (en)
Inventor
Guido Kurz
Juan CAMACHO GÓMEZ
Original Assignee
Oncostellae, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncostellae, S.L. filed Critical Oncostellae, S.L.
Publication of CY1124087T1 publication Critical patent/CY1124087T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/082Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/087Arrangement or mounting of control or safety devices of electric circuits regulating heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Combustion & Propulsion (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY20211100437T 2017-06-01 2021-05-20 Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων CY1124087T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201730759 2017-06-01
PCT/ES2018/070396 WO2018220252A1 (es) 2017-06-01 2018-05-31 Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa

Publications (1)

Publication Number Publication Date
CY1124087T1 true CY1124087T1 (el) 2022-05-27

Family

ID=61569288

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100437T CY1124087T1 (el) 2017-06-01 2021-05-20 Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων

Country Status (22)

Country Link
US (1) US11021479B2 (https=)
EP (1) EP3632912B1 (https=)
JP (1) JP7110335B2 (https=)
KR (1) KR102629854B1 (https=)
CN (1) CN111247143B (https=)
AU (1) AU2018278283B2 (https=)
CA (1) CA3066009A1 (https=)
CY (1) CY1124087T1 (https=)
DK (1) DK3632912T3 (https=)
EA (1) EA037384B1 (https=)
ES (1) ES2881960T3 (https=)
HR (1) HRP20210814T1 (https=)
HU (1) HUE054792T2 (https=)
LT (1) LT3632912T (https=)
MX (1) MX385475B (https=)
PL (1) PL3632912T3 (https=)
PT (1) PT3632912T (https=)
RS (1) RS61833B1 (https=)
SI (1) SI3632912T1 (https=)
SM (1) SMT202100312T1 (https=)
WO (1) WO2018220252A1 (https=)
ZA (1) ZA201908372B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7525609B2 (ja) 2020-01-31 2024-07-30 エルジー エナジー ソリューション リミテッド 多層構造の無機物層を含む分離膜一体型電極の製造方法及びそれによる分離膜一体型電極

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551460A (en) 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
DE69713139T2 (de) * 1996-11-26 2002-12-19 American Cyanamid Co., Madison Hetero-biaryl-pyridochinazolinonderivate als antikrebsmittel
US20050192314A1 (en) * 2003-11-13 2005-09-01 Ambit Biosciences Corporation Urea derivatives as C-kit modulators
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2010061971A1 (ja) 2008-11-28 2010-06-03 興和株式会社 ピリジン-3-カルボキシアミド誘導体
EP3119781B1 (en) * 2014-03-20 2020-09-16 The Johns Hopkins University Compounds which inhibit rna polymerase, compositions including such compounds, and their use

Also Published As

Publication number Publication date
AU2018278283A1 (en) 2019-12-19
JP7110335B2 (ja) 2022-08-01
BR112019024892A2 (pt) 2020-06-16
EP3632912A1 (en) 2020-04-08
EA037384B1 (ru) 2021-03-23
RS61833B1 (sr) 2021-06-30
CA3066009A1 (en) 2018-12-06
LT3632912T (lt) 2021-06-10
AU2018278283B2 (en) 2021-06-17
MX385475B (es) 2025-03-18
US20200148676A1 (en) 2020-05-14
JP2020521817A (ja) 2020-07-27
CN111247143A (zh) 2020-06-05
PL3632912T3 (pl) 2021-09-06
PT3632912T (pt) 2021-06-02
HRP20210814T1 (hr) 2021-06-25
US11021479B2 (en) 2021-06-01
DK3632912T3 (da) 2021-05-10
SMT202100312T1 (it) 2021-07-12
KR102629854B1 (ko) 2024-01-25
HUE054792T2 (hu) 2021-09-28
CN111247143B (zh) 2022-07-05
KR20200011990A (ko) 2020-02-04
SI3632912T1 (sl) 2021-08-31
ES2881960T3 (es) 2021-11-30
WO2018220252A1 (es) 2018-12-06
MX2019014436A (es) 2020-02-10
ZA201908372B (en) 2021-04-28
EP3632912B1 (en) 2021-03-17
EA201992793A1 (ru) 2020-03-26

Similar Documents

Publication Publication Date Title
CO2021005987A2 (es) Compuestos de anillo fusionado
CY1123595T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5
CL2021000387A1 (es) Compuestos de anillo fusionado
CY1122046T1 (el) Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
EA202090688A1 (ru) Бис-амидные соединения, активирующие саркомер, и варианты их применения
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA202090014A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
EA202190588A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
SA521422152B1 (ar) Vanin مركبات عطرية غير متجانسة كمثبطات
CL2020001020A1 (es) Derivados de bencimidazol y sus usos.
CY1123722T1 (el) Ενεσιμα φαρμακευτικα σκευασματα λεφαμουλινης
MX2020001531A (es) Nuevos compuestos hetorociclicos como inhibidores de cdk8/19.
CY1122077T1 (el) Νεα δακτυλιωμενα φαινοξυακεταμιδια
EA202191478A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
CY1123880T1 (el) Καινοτομοι 5-ητ2 ανταγωνιστες
CY1122381T1 (el) Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta
EA201991355A1 (ru) Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта
CY1123185T1 (el) Παραγωγα ινδολιου
EA202191477A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
EA202191378A1 (ru) Активные сложноэфирные производные тестостерона, их композиции и применения
CY1124087T1 (el) Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων
EA202092446A1 (ru) ТИАЗОЛ- ИЛИ ТИАДИАЗОЛЗАМЕЩЕННЫЕ АРИЛЬНЫЕ И ГЕТЕРОАРИЛЬНЫЕ ПРОИЗВОДНЫЕ КАК ИНГИБИТОРЫ Vps34